NCT00381537已完成不适用
Prediction of Childhood Epilepsy Outcome in Bangladesh
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 92
- 试验地点
- 3
研究概览
简要总结
Randomised controlled trial of the use of phenobarbitone and carbamazepine in childhood epilepsy in Bangladesh with particular reference to behavioural side effects.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 盲法
- None
入排标准
- 年龄范围
- 2 Years 至 16 Years（Child）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Active epilepsy
- •Aged 2-15 years
排除标准
- •Excluded absence
- •Myoclonic and malignant epilepsy syndromes
- •Major motor and cognitive impairments
- •Those currently receiving antiepilepsy drugs.
研究者
研究点 (3)
Loading locations...
相似试验
已完成
4 期
Study of Efficacy of Carbamazepine in Therapy of Patients With Moderate Persistent and Severe Bronchial AsthmaBronchial AsthmaNCT00153296Centre of Chinese Medicine, Georgia68
进行中（未招募）
1 期
Cannabidiol in Children With Refractory Epileptic EncephalopathyEpileptic EncephalopathyNCT03024827University of Saskatchewan20
已完成
4 期
Antiepileptic Drug Carbamazepine in Treatment of Bronchial AsthmaBronchial AsthmaNCT00207428Centre of Chinese Medicine, Georgia65
已完成
3 期
GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet SyndromeDravet SyndromeEpilepsyNCT02224703Jazz Pharmaceuticals199
已完成
3 期
Antiepileptic Efficacy Study of GWP42003-P in Children and Young Adults With Dravet Syndrome (GWPCARE1)Dravet SyndromeEpilepsyNCT02091375Jazz Pharmaceuticals120